Cite

HARVARD Citation

    Xu, Y. et al. (2021). Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma. Human vaccines & immunotherapeutics. 17 (7), pp. 1882-1896. [Online]. 
  
Back to record